Development in PaCO<sub>2</sub> over 12 months in patients with COPD with persistent hypercapnic respiratory failure treated with high-flow nasal cannula-post-hoc analysis from a randomised controlled trial.

BMJ Open Respir Res · 2020 · PMC7677330 · PMID 33208303

Europe PMC DOI

hedged sentence

0.0140

closest p · 0.3× alpha

0.0140

boldest claim

The sentences

near-significantp=0.014actually significant

Significant or near-significant changes over 12 months in PaO 2 were similar between groups: controls (ΔPaO 2 =−0.45 kPa, p=0.014); HFNC-treated, (ΔPaO 2 =−0.31 kPa, p=0.062).

also in 2,306 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.